Asymmetric dimethylarginine and angiogenesis: biological significance

Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study

(2016) Janine Wirth et al.   AMINO ACIDS

Considerable impacts of AGXT2 V140I polymorphism on chronic heart failure in the Chinese population

(2016) Xiao-Lei Hu et al.   ATHEROSCLEROSIS

Assessment of ADMA, estradiol, and progesterone in severe preeclampsia

(2016) Jing-Jie Zheng et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis

(2016) Clemens Lange et al.   EXPERIMENTAL EYE RESEARCH

Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase

(2016) Chiao‐Po Hsu et al.   Journal of the American Heart Association

CT-1 induces angiogenesis by regulating the ADMA/DDAH Pathway

(2015) Zhen Zhong Zheng et al.   BIOMEDICAL PAPERS-OLOMOUC

Asymmetric Dimethyl-l-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease

(2015) Zhen-fei Fang et al.   PEDIATRIC CARDIOLOGY

Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease - a One-Year Follow-Up Study

(2014) Jaromír Eiselt et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Endothelial Dysfunction and Brachial Intima-Media Thickness: Long Term Cardiovascular Risk with Claudication Related to Peripheral Arterial Disease: A Prospective Analysis

(2014) Franz Hafner et al.   PLoS One

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

(2013) Andrzej Surdacki et al.   Cardiovascular Diabetology

DDAH1 Deficiency Attenuates Endothelial Cell Cycle Progression and Angiogenesis

(2013) Ping Zhang et al.   PLoS One

Asymmetric Dimethyarginine as Marker and Mediator in Ischemic Stroke

(2012) Shufen Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: A randomized controlled trial

(2011) Oliver Schlager et al.   ATHEROSCLEROSIS

In vivo nitric oxide synthesis, insulin sensitivity, and asymmetric dimethylarginine in obese subjects without and with metabolic syndrome

(2011) Mario Siervo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome

(2011) Iván Palomo et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

The ADMA/DDAH Pathway Regulates VEGF-Mediated Angiogenesis

(2009) Lorna R Fiedler et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The DDAH/ADMA pathway in the control of endothelial cell migration and angiogenesis

(2009) Lorna R. Fiedler et al.   BIOCHEMICAL SOCIETY TRANSACTIONS